Sensyne Health announces Dr. Ian Hudson to its Board as Independent Director

By Debbie Wright

Sensyne Health announces Dr. Ian Hudson to its Board as Independent Director

June 18, 2021 by Olivier Dellacherie – Talent4Boards – UK, Oxford –  Sensyne Health plc (LON: SENS), the Clinical AI company, today announced the appointment of Dr. Ian Hudson to its Board as Independent Non-Executive Director with effect from 28 June 2021. About Dr. Ian Hudson Dr. Hudson has extensive knowledge of the healthcare and pharmaceutical sector, having served as Chief Executive of the UK’s Medicines and Healthcare Products Regulatory Agency between 2013 and 2019. Before this, he was the MHRA’s Licensing Director, responsible for most of the agency’s medicines licensing activities. Before joining the MHRA, Dr. Hudson held various senior roles at SmithKline Beecham, working […]

From:: Sensyne Health announces Dr. Ian Hudson to its Board as Independent Director